BridgeMD
New treatment option for Gastric Cancer Stage II
Official title Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer
ClinicalTrials.gov ID: NCT06755554
What this study is testing
What is Endoscopic injection of Indocyanine green?
Endoscopic injection of Indocyanine green is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for gastric cancer stage ii.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to evaluate the safety and benefits of using indocyanine green in lymph node dissection for gastric cancer surgery. The primary endpoint is the average number of lymph nodes removed.
- Phase 3: a large, late-stage study
- Time commitment: about 5 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Tumor spread: cT2-4a cN0-3,
- cM0;
- Age: 18 - 80;
- Gender: men and women;
- ECOG: 0 - 1;
You likely can't join if
- M1 (distant metastases);
- ECOG 2 - 4;
- Age over 80 and under 18;
- Presence of severe comorbidities, ASA\> 3;
- Patient refusal to participate in the study.
See the full eligibility criteria
- Tumor spread: cT2-4a cN0-3,
- cM0;
- Age: 18 - 80;
- Gender: men and women;
- ECOG: 0 - 1;
- Histologic type of tumor: Adenocarcinoma of any subtype;
- Degree of differentiation: G1 - G4;
- Tumor localization: cardiac region, stomach floor, stomach body, antrum, pylorus, and pyloric region of the stomach;
- Tumor spread: absence of tumor invasion into adjacent structures;
- No history of cancer in the last 5 years;
- No previous chemotherapy, surgery or radiation treatment for another cancer (except for neoadjuvant chemotherapy for gastric cancer);
- Absence of severe comorbidity restricting laparoscopic approach.
- M1 (distant metastases);
- ECOG 2 - 4;
- Age over 80 and under 18;
- Presence of severe comorbidities, ASA\> 3;
- Patient refusal to participate in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Kyiv, Ukraine
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 5 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kyiv, Ukraine. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.